Undral Munkhsaikhan

Dr. Undral Munkhsaikhan

Lincoln Memorial University, Knoxville, Tennessee, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2019 in JCI Insight
Verified
Journal Article
Closed access
PDF file
ZXZhousheng Xiao
Zhousheng Xiao
GKGwendalyn King
Gwendalyn King
SMSalvatore Mancarella
Salvatore Mancarella
Undral MunkhsaikhanUndral Munkhsaikhan
Undral Munkhsaikhan
LCLi Cao
Li Cao
LQLeigh Darryl Quarles
Leigh Darryl Quarles
Observations in transgenic α- Klotho ( Kl ) mice ( Kl Tg ) defined the antiaging role of soluble Klotho (sKL 130 ). A genetic translocation that elevates sKL levels in humans is paradoxically associated with increased circulating fibroblast growth factor 23 (FGF23) levels and the potential of both membrane KL (mKL 135 ) and sKL 130 to act as coreceptors for FGF23 activation of fibroblast growth factor receptors (FGFRs). Neither FGF23 expression nor the contributions of FGF23, mKL 135 , and sKL 130 codependent and independent functions have been investigated in Kl Tg mice. In the current study, we examined the effects of Kl overexpression on FGF23 levels and functions in Kl Tg mice. We found that mKL 135 but not sKL 130 stimulated FGF23 expression in osteoblasts, leading to elevated Fgf23 bone expression and circulating levels in Kl Tg mice. Elevated FGF23 suppressed 1,25(OH) 2 D and parathyroid hormone levels but did not cause hypophosphatemic rickets in Kl Tg mice. Kl Tg mice developed low aldosterone–associated hypertension but not left ventricular hypertrophy. Mechanistically, we found that mKL 135 and sKL 130 are essential cofactors for FGF23-mediated ERK activation but that they inhibited FGF23 stimulation of PLC-γ and PI3K/AKT signaling. Thus, increased longevity in Kl Tg mice occurs in the presence of excess FGF23 that interacts with mKL and sKL to bias FGFR pathways.

10 January 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
Modar KassanModar Kassan
Modar Kassan
YKYoungin Kwon
Youngin Kwon
Undral MunkhsaikhanUndral Munkhsaikhan
Undral Munkhsaikhan
ASAmal Sahyoun
Amal Sahyoun
Tauheed IshratTauheed Ishrat
Tauheed Ishrat
Karima Ait-AissaKarima Ait-Aissa
Karima Ait-Aissa
Objectives: Short-chain fatty acids (SCFAs), the main metabolites released from the gut microbiota, are altered during hypertension and obesity. SCFAs play a beneficial role in the cardiovascular system. However, the effect of SCFAs on cerebrovascular endothelial cells is yet to be uncovered. In this study, we use brain endothelial cells to investigate the in vitro effect of SCFAs on heme oxygenase 2 (HO-2) and mitochondrial function after angiotensin II (Ang-II) treatment. Methods: Brain human microvascular endothelial cells were treated with Ang-II (500 nM for 24 h) in the presence and absence of an SCFAs cocktail (1 μM; acetate, propionate, and butyrate) and/or HO-2 inhibitor (SnPP 5 μM). At the end of the treatment, HO-2, endothelial markers (p-eNOS and NO production), inflammatory markers (TNFα, NFκB-p50, and -p65), calcium homeostasis, mitochondrial membrane potential, mitochondrial ROS and H2O2, and mitochondrial respiration were determined in all groups of treated cells. Key Results: Our data showed that SCFAs rescued HO-2 after Ang-II treatment. Additionally, SCFAs rescued Ang-II-induced eNOS reduction and mitochondrial membrane potential impairment and mitochondrial respiration damage. On the other hand, SCFAs reduced Ang-II-induced inflammation, calcium dysregulation, mitochondrial ROS, and H2O2. All of the beneficial effects of SCFAs on endothelial cells and mitochondrial function occurred through HO-2. Conclusions: SCFAs treatment restored endothelial cells and mitochondrial function following Ang-II-induced oxidative stress. SCFAs exert these beneficial effects by acting on HO-2. Our results are opening the door for more studies to investigate the effect the of SCFAs/HO-2 axis on hypertension and obesity-induced cerebrovascular diseases.

12 November 2021 in Physiological Genomics
Verified
Journal Article
Open access
PDF file
QGQingqing Gu
Qingqing Gu
FXFuyi Xu
Fuyi Xu
BOBuyan-Ochir Orgil
Buyan-Ochir Orgil
ZKZaza Khuchua
Zaza Khuchua
Undral MunkhsaikhanUndral Munkhsaikhan
Undral Munkhsaikhan
LLLu Lu
Lu Lu
Broad cellular functions and diseases including muscular dystrophy, arrhythmogenic right ventricular cardiomyopathy (ARVC5) and cancer are associated with transmembrane protein43 (TMEM43/ LUMA). The study aimed to investigate biological roles of TMEM43 through genetic regulation, gene pathways and gene networks, candidate interacting genes, and up- or downstream regulators. Cardiac transcriptomes from 40 strains of recombinant inbred BXD mice and two parental strains representing murine genetic reference population (GRP) were applied for genetic correlation, functional enrichment, and coexpression network analysis using systems genetics approach. The results were validated in a newly created knock-in Tmem43-S358L mutation mouse model (Tmem43S358L) that displayed signs of cardiac dysfunction, resembling ARVC5 phenotype seen in humans. We found high Tmem43 levels among BXDs with broad variability in expression. Expression of Tmem43 highly negatively correlated with heart mass and heart rate among BXDs, whereas levels of Tmem43 highly positively correlated with plasma high-density lipoproteins (HDL). Through finding differentially expressed genes (DEGs) between Tmem43S358L mutant and wild-type (Tmem43WT) lines, 18 pathways (out of 42 found in BXDs GRP) that are involved in ARVC, hypertrophic cardiomyopathy, dilated cardiomyopathy, nonalcoholic fatty liver disease, Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease were verified. We further constructed Tmem43-mediated gene network, in which Ctnna1, Adcy6, Gnas, Ndufs6, and Uqcrc2 were significantly altered in Tmem43S358L mice versus Tmem43WT controls. Our study defined the importance of Tmem43 for cardiac- and metabolism-related pathways, suggesting that cardiovascular disease-relevant risk factors may also increase risk of metabolic and neurodegenerative diseases via TMEM43-mediated pathways.

20 November 2020 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
FXFuyi Xu
Fuyi Xu
JGJun Gao
Jun Gao
Undral MunkhsaikhanUndral Munkhsaikhan
Undral Munkhsaikhan
NLNing Li
Ning Li
QGQingqing Gu
Qingqing Gu
LLLu Lu
Lu Lu
Background: A high inflammatory and cytokine burden that induces vascular inflammation, myocarditis, cardiac arrhythmias, and myocardial injury is associated with a lethal outcome in COVID-19. The SARS-CoV-2 virus utilizes the ACE2 receptor for cell entry in a similar way to SARS-CoV. This study investigates the regulation, gene network, and associated pathways of ACE2 that may be involved in inflammatory and cardiovascular complications of COVID-19.Methods: Cardiovascular traits were determined in the one of the largest mouse genetic reference populations: BXD recombinant inbred strains using blood pressure, electrocardiography, and echocardiography measurements. Expression quantitative trait locus (eQTL) mapping, genetic correlation, and functional enrichment analysis were used to identify Ace2 regulation, gene pathway, and co-expression networks.Results: A wide range of variation was found in expression of Ace2 among the BXD strains. Levels of Ace2 expression are negatively correlated with cardiovascular traits, including systolic and diastolic blood pressure and P wave duration and amplitude. Ace2 co-expressed genes are significantly involved in cardiac- and inflammatory-related pathways. The eQTL mapping revealed that Cyld is a candidate upstream regulator for Ace2. Moreover, the protein–protein interaction (PPI) network analysis inferred several potential key regulators (Cul3, Atf2, Vcp, Jun, Ppp1cc, Npm1, Mapk8, Set, Dlg1, Mapk14, and Hspa1b) for Ace2 co-expressed genes in the heart.Conclusions:Ace2 is associated with blood pressure, atrial morphology, and sinoatrial conduction in BXD mice. Ace2 co-varies with Atf2, Cyld, Jun, Mapk8, and Mapk14 and is enriched in the RAS, TGFβ, TNFα, and p38α signaling pathways, involved in inflammation and cardiac damage. We suggest that all these novel Ace2-associated genes and pathways may be targeted for preventive, diagnostic, and therapeutic purposes in cardiovascular damage in patients with systemic inflammation, including COVID-19 patients.

26 May 2020 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
YCYuanjian Chen
Yuanjian Chen
FXFuyi Xu
Fuyi Xu
Undral MunkhsaikhanUndral Munkhsaikhan
Undral Munkhsaikhan
CBCharlie Boyle
Charlie Boyle
TBTheresa Borcky
Theresa Borcky
YSYao Sun
Yao Sun

25 July 2019 in Circulation Journal
Verified
Journal Article
Open access
PDF file
KHKeiichi Hirono
Keiichi Hirono
KSKazuyoshi Saito
Kazuyoshi Saito
Undral MunkhsaikhanUndral Munkhsaikhan
Undral Munkhsaikhan
FXFuyi Xu
Fuyi Xu
CWCe Wang
Ce Wang
EPEnkhsaikhan Purevjav
Enkhsaikhan Purevjav
Background:Left ventricular non-compaction (LVNC) is a heritable cardiomyopathy characterized by hypertrabeculation, inter-trabecular recesses and thin compact myocardium, but the genetic basis and mechanisms remain unclear. This study identified novel LVNC-associated mutations inNOTCH-dependent genes and investigated their mutational effects.Methods and Results:High-resolution melting screening was performed in 230 individuals with LVNC, followed by whole exome and Sanger sequencing of available family members. Dimerization of bone morphogenetic protein 10 (BMP10) and its binding to BMP receptors (BMPRs) were evaluated. Cellular differentiation, proliferation and tolerance to mechanical stretch were assessed in H9C2 cardiomyoblasts, expressing wild-type (WT) or mutant BMP10 delivered by adenoviral vectors. Rare variants, p.W143*-NRG1and p.V407I-BMP10, were identified in 2 unrelated probands and their affected family members. Although dimerization of mutant V407I-BMP10 was preserved like WT-BMP10, V407I-BMP10 pulled BMPR1a and BMPR2 receptors more weakly compared with WT-BMP10. On comparative gene expression and siRNA analysis, expressed BMPR1a and BMPR2 receptors were responsive to BMP10 treatment in H9C2 cardiomyoblasts. Expression of V407I-BMP10 resulted in a significantly lower rate of proliferation in H9C2 cells compared with WT-BMP10. Cyclic stretch resulted in destruction and death of V407I-BMP10 cells.Conclusions:The W143*-NRG1and V470I-BMP10variants are associated with LVNC. Impaired BMPR-binding ability, perturbed proliferation and differentiation processes and intolerance to stretch in V407I-BMP10 mutant cardiomyoblasts may underlie myocardial non-compaction.